ClinConnect ClinConnect Logo
Search / Trial NCT06583460

Systematic Intervention to Improve Sexual Dysfunction

Launched by CENTER EUGENE MARQUIS · Sep 2, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Sexual Dysfunction

ClinConnect Summary

This clinical trial is looking at how different types of care can help improve sexual health for women who have localized breast cancer. The study compares two approaches: one where women receive ongoing, organized support from a team of specialists focused on sexual health (called oncosexological care), and another where help is available only when women ask for it. The goal is to see which method works better in enhancing sexual well-being.

To participate, women must be 18 years or older and have localized breast cancer, meaning the cancer hasn't spread far. They should be starting treatment that includes surgery and possibly other therapies like chemotherapy or hormone therapy. Unfortunately, women who have had other types of cancer recently, are pregnant or breastfeeding, or have certain legal restrictions cannot join. If eligible, participants can expect to receive support and information about their sexual health throughout their treatment. This study aims to ensure that women dealing with breast cancer have the resources they need for a better quality of life.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women ≥ 18 years (menopausal or not),
  • Localized breast cancer with or without lymph node involvement,
  • Initial treatment starting with surgical resection, whatever the associated therapy (chemotherapy, radiotherapy, hormone therapy, monoclonal antibody, conjugated drug antibody, targeted therapy such as cyclin and anti-PARP inhibitors, etc.),
  • Patient affiliated or benefiting from the social security system,
  • Patient informed and informed consent signed.
  • Exclusion Criteria:
  • History of cancer (except squamous cell carcinoma or basal cell carcinoma) in the last five years,
  • Pregnant or breast-feeding women,
  • Patients deprived of their liberty, under guardianship or curatorship and all other administrative safeguards,
  • Patients unable to comply with the study schedule for social, medical or psychological reasons.

About Center Eugene Marquis

Center Eugene Marquis is a leading clinical research organization dedicated to advancing oncology through innovative research and patient-centered care. Located in Rennes, France, the center specializes in conducting high-quality clinical trials aimed at evaluating new therapies and improving treatment outcomes for cancer patients. With a multidisciplinary team of experienced professionals and state-of-the-art facilities, Center Eugene Marquis collaborates with academic institutions, pharmaceutical companies, and other stakeholders to foster groundbreaking discoveries and contribute to the global fight against cancer.

Locations

Rennes, Bretagne, France

Patients applied

0 patients applied

Trial Officials

Claudia Lefeuvre-Plesse, MD

Principal Investigator

Centre de Lutte Contre Le cancer Eugène Marquis

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported